A more accurate name would be “You Can See Everything That We Chose To Point The Camera At,”Theranos whistleblower Tyler ...

A new division in the National Institutes of Health and a new task force within the White House will advance the cause of ...

The Republican party’s confusing messaging on vaccines is going to hurt candidates in the midterms, two former GOP congressmen argue.

Roche is reviewing all future investments in Germany over health care cost-cutting ​policies, with a top executive citing a ...

China is proposing new restrictions on foreign acquisitions of critical biopharma technologies, as the country seeks to ...

We dig into trust, prices, and a bit of baseball in this week's Health Care Inc. newsletter.

A STAT investigation found that several nonprofits are raking in massive sums by acting as arbitrators in a program that ...

Internal emails obtained by STAT show that the American Association of Immunologists is sharply divided over California's ...

Isomorphic Labs wants to turn its technology into an engine for new medicines. The question now is whether — and how — it can ...

Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the ...

Three former FDA chiefs lit into the Trump administration, criticizing the now former FDA officials who oversaw a massive ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...